HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshinao Oda Selected Research

Prostatic Neoplasms (Prostate Cancer)

4/2023Interstitial pneumonia after regression by olaparib for neuroendocrine prostate cancer with BRCA1 mutation: a case report.
2/2022Clinical impact of HSD3B1 polymorphism by metastatic volume and somatic HSD3B1 alterations in advanced prostate cancer.
4/2021Salvage robot-assisted radical prostatectomy after carbon ion radiotherapy: a case report.
1/2021Gene amplification of YB-1 in castration-resistant prostate cancer in association with aberrant androgen receptor expression.
12/2020A rare case of PSA-negative metastasized prostate cancer to the stomach with serum CEA and CA19-9 elevation: a case report.
4/2018Progression to bone-marrow carcinomatosis and extraosseous legion during treatment with radium-223 for multiple bone metastases.
1/2017FOXO3a Expression Regulated by ERK Signaling is Inversely Correlated With Y-Box Binding Protein-1 Expression in Prostate Cancer.
7/2016Potential Role for YB-1 in Castration-Resistant Prostate Cancer and Resistance to Enzalutamide Through the Androgen Receptor V7.
1/2016The Expression of Ubiquitous Mitochondrial Creatine Kinase Is Downregulated as Prostate Cancer Progression.
12/2015Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshinao Oda Research Topics

Disease

394Neoplasms (Cancer)
05/2024 - 01/2002
66Neoplasm Metastasis (Metastasis)
05/2024 - 01/2006
54Carcinoma (Carcinomatosis)
05/2024 - 12/2002
43Adenocarcinoma
05/2024 - 10/2006
32Sarcoma (Soft Tissue Sarcoma)
06/2023 - 10/2003
29Hepatocellular Carcinoma (Hepatoma)
02/2024 - 11/2006
27Carcinogenesis
04/2024 - 01/2006
27Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2023 - 08/2016
24Pancreatic Neoplasms (Pancreatic Cancer)
05/2024 - 10/2010
24Adenocarcinoma of Lung
04/2024 - 07/2011
22Stomach Neoplasms (Stomach Cancer)
01/2022 - 10/2006
19Lung Neoplasms (Lung Cancer)
10/2023 - 07/2016
17Prostatic Neoplasms (Prostate Cancer)
04/2023 - 02/2010
16Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 12/2008
15Synovial Sarcoma (Synovioma)
01/2022 - 04/2002
14Colorectal Neoplasms (Colorectal Cancer)
03/2024 - 02/2009
13Rhabdoid Tumor (Rhabdoid Tumors)
01/2021 - 02/2002
12Lymphatic Metastasis
08/2023 - 02/2007
12Neoplasms, Cystic, Mucinous, and Serous
07/2018 - 11/2010
11Adenoma (Adenomas)
04/2024 - 10/2010
11Leiomyosarcoma
01/2024 - 10/2004
11Esophageal Squamous Cell Carcinoma
04/2023 - 12/2014
11Breast Neoplasms (Breast Cancer)
01/2022 - 02/2003
10Cholangiocarcinoma
05/2023 - 09/2010
9Renal Cell Carcinoma (Grawitz Tumor)
05/2024 - 07/2008
9Papillomavirus Infections
03/2024 - 01/2013
9Microsatellite Instability
01/2023 - 09/2003
9Infections
01/2022 - 06/2014
9Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2020 - 07/2005
8Hypoxia (Hypoxemia)
07/2023 - 09/2014
8Liposarcoma
05/2023 - 09/2002
8Melanoma (Melanoma, Malignant)
02/2023 - 08/2004
8Fibrosis (Cirrhosis)
06/2022 - 04/2016
8Neuroendocrine Tumors (Neuroendocrine Tumor)
02/2021 - 01/2014
8Primitive Neuroectodermal Tumors (PNET)
01/2019 - 10/2003
8Neurofibrosarcoma (MPNST)
01/2018 - 05/2005
7Small Cell Lung Carcinoma (Small Cell Lung Cancer)
03/2024 - 04/2015
7Osteosarcoma (Osteogenic Sarcoma)
01/2024 - 02/2003
7Triple Negative Breast Neoplasms
09/2023 - 01/2016
7Ewing Sarcoma (Sarcoma, Ewing)
03/2023 - 10/2003
7Chondrosarcoma
01/2022 - 07/2006
7Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
12/2019 - 01/2002
6Rectal Neoplasms (Rectal Cancer)
03/2024 - 05/2016
6Liver Cirrhosis (Hepatic Cirrhosis)
01/2024 - 09/2010
6Rhabdomyosarcoma
10/2023 - 06/2004
6Myxoid Liposarcoma
03/2023 - 12/2005

Drug/Important Bio-Agent (IBA)

91Proteins (Proteins, Gene)FDA Link
05/2024 - 02/2003
46Biomarkers (Surrogate Marker)IBA
04/2024 - 05/2005
35LigandsIBA
10/2023 - 07/2002
32Messenger RNA (mRNA)IBA
03/2024 - 01/2002
30B7-H1 AntigenIBA
01/2022 - 01/2015
23Immune Checkpoint InhibitorsIBA
05/2024 - 07/2017
23ParaffinIBA
07/2023 - 09/2002
20Formaldehyde (Formol)FDA Link
07/2023 - 09/2002
19DNA (Deoxyribonucleic Acid)IBA
05/2024 - 04/2002
18ErbB Receptors (EGF Receptor)IBA
02/2023 - 05/2005
18Cadherins (E-Cadherin)IBA
01/2022 - 09/2003
15Indicators and Reagents (Reagents)IBA
09/2020 - 02/2002
15VimentinIBA
01/2020 - 02/2002
14Small Interfering RNA (siRNA)IBA
01/2019 - 01/2009
13RNA (Ribonucleic Acid)IBA
04/2024 - 01/2019
12AntigensIBA
01/2023 - 06/2014
11Cyclin D1IBA
01/2020 - 01/2002
10CytokinesIBA
03/2024 - 01/2013
10AntibodiesIBA
02/2024 - 06/2014
10CateninsIBA
01/2024 - 01/2011
10MicroRNAs (MicroRNA)IBA
10/2023 - 11/2011
10Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2017 - 05/2006
10beta CateninIBA
02/2010 - 01/2002
9Transcription Factors (Transcription Factor)IBA
07/2022 - 11/2004
9Keratins (Keratin)IBA
11/2021 - 02/2002
9MucinsIBA
01/2021 - 10/2010
8EnzymesIBA
03/2024 - 03/2011
8Fetal Proteins (Fetoprotein)IBA
01/2024 - 10/2011
8Forkhead Transcription Factors (Forkhead Box Proteins)IBA
05/2021 - 09/2015
7NivolumabIBA
05/2024 - 07/2016
7alpha-Fetoproteins (alpha-Fetoprotein)IBA
05/2024 - 12/2007
7Carrier Proteins (Binding Protein)IBA
05/2024 - 02/2003
7Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
11/2023 - 01/2018
7Eosine Yellowish-(YS) (Eosin)IBA
06/2023 - 08/2009
7Phosphotransferases (Kinase)IBA
08/2022 - 10/2006
7Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2017 - 07/2006
6AntioxidantsIBA
05/2024 - 02/2012
6Paclitaxel (Taxol)FDA LinkGeneric
04/2024 - 07/2007
6Hematoxylin (Haematoxylon)IBA
06/2023 - 08/2009
6Doxorubicin (Adriamycin)FDA LinkGeneric
03/2023 - 07/2009
6Insulin-Like Growth Factor II (Somatomedin A)IBA
01/2023 - 09/2013

Therapy/Procedure

83Therapeutics
05/2024 - 01/2006
58Drug Therapy (Chemotherapy)
05/2024 - 10/2003
30Immunotherapy
03/2024 - 02/2015
18Radiotherapy
03/2024 - 10/2003
15Neoadjuvant Therapy
04/2024 - 12/2015
14Pancreatectomy
05/2024 - 10/2010
10Gastrectomy
01/2021 - 09/2012
9Adjuvant Chemotherapy
02/2024 - 08/2004
8Chemoradiotherapy
03/2024 - 05/2014
8Liver Transplantation
01/2024 - 12/2007
8Lymph Node Excision (Lymph Node Dissection)
01/2023 - 05/2016
8Castration
02/2022 - 08/2011
6Pancreaticoduodenectomy
10/2023 - 10/2010